Who is sponsoring NCT04736979?

NCT04736979 is sponsored by University Hospital of Ferrara.

What drugs are being tested in NCT04736979?

Interventions in NCT04736979: amoxicillin clavulanate.

What condition does NCT04736979 study?

NCT04736979 studies Device Related Infection.

Is NCT04736979 still recruiting?

NCT04736979 is currently completed. Last updated 29 April 2022.

Last reviewed 2022-04-29 · How we verify

NCT04736979: PRACTICE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Antibiotic PRophylAxis Based on infeCTIve Risk in Cardiac Implantable Electronic Device

Completed Last updated 29 April 2022

What this trial tests

trial testing amoxicillin clavulanate in Device Related Infection in 1,044 participants. Completed in 31 August 2020.

Timeline

1 January 2017

Primary endpoint
31 August 2020

31 August 2020

Quick facts

Lead sponsor	University Hospital of Ferrara
Status	Completed
Study type	OBSERVATIONAL
Enrollment	1,044
Start date	1 January 2017
Primary completion	31 August 2020
Estimated completion	31 August 2020

Drugs / interventions tested

amoxicillin clavulanate

Conditions studied

Device Related Infection — all drugs for Device Related Infection →

Sponsor

University Hospital of Ferrara

Who can join

18 and older, any sex, with Device Related Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was aimed at the evaluation of a new protocol of antibiotic prophylaxis, stratified according to individual infective risk calculated with the Shariff score at the moment of cardiac implantable electronic device (CIED) implantation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Antibiotic prophylaxis based on individual infective risk stratification in cardiac implantable electronic device: the PRACTICE study.
Malagù M, Vitali F, Brieda A, Cimaglia P, et al · · 2022 · cited 15× · PMID 34487163 · DOI 10.1093/europace/euab222

Verify or expand the search:

Other University Hospital of Ferrara trials

Trials by the same sponsor.

NCT07244562 — Effects of Physical Exercise and Cognitive Training on Quality of Life in Older Women · NA · not yet recruiting
NCT07244536 — Effects of Physical Exercise and Cognitive Training on Quality of Life in Elderly Adults · NA · recruiting
NCT07118761 — Home-based Empowerment Through Physical Exercise Assisted by Technology for Frail Patients · NA · not yet recruiting
NCT06679517 — Observational Study Relating to the Long-term Follow-up of Patients with Severe Aortic Stenosis Evaluated for Percutaneo · enrolling by invitation
NCT07058896 — Unravelling The Optimisation And Consolidation Of Motor Skills In People With Multiple Sclerosis With Severe Gait Impair · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04736979 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital of Ferrara
Last refreshed: 29 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04736979.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing